27
Participants
Start Date
February 28, 2011
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Filgrastim
Given SC
Laboratory Biomarker Analysis
Correlative studies
Pegfilgrastim
Given SC
Topotecan Hydrochloride
Given IV
Veliparib
Given PO
North Shore University Hospital, Manhasset
Long Island Jewish Medical Center, New Hyde Park
North Shore-LIJ Health System/Center for Advanced Medicine, New Hyde Park
State University of New York Downstate Medical Center, Brooklyn
Abington Memorial Hospital, Abington
Fox Chase Cancer Center, Philadelphia
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Virginia Commonwealth University/Massey Cancer Center, Richmond
Memorial University Medical Center, Savannah
Florida Hospital Orlando, Orlando
University of Mississippi Medical Center, Jackson
Riverside Methodist Hospital, Columbus
Lake University Ireland Cancer Center, Mentor
Case Western Reserve University, Cleveland
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
Saint Joseph Mercy Port Huron, Port Huron
Michigan Cancer Research Consortium CCOP, Ann Arbor
Oakwood Hospital and Medical Center, Dearborn
Saint Mary Mercy Hospital, Livonia
Saint John Hospital and Medical Center, Detroit
Saint Joseph Mercy Oakland, Pontiac
Genesys Regional Medical Center, Grand Blanc
Hurley Medical Center, Flint
Saint Mary's of Michigan, Saginaw
Sparrow Hospital, Lansing
Borgess Medical Center, Kalamazoo
Bronson Methodist Hospital, Kalamazoo
West Michigan Cancer Center, Kalamazoo
Allegiance Health, Jackson
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Oconomowoc Memorial Hospital-ProHealth Care Inc, Oconomowoc
D N Greenwald Center, Mukwonago
Waukesha Memorial Hospital, Waukesha
Sudarshan K Sharma MD Limted-Gynecologic Oncology, Hinsdale
Decatur Memorial Hospital, Decatur
Memorial Medical Center, Springfield
Cancer Research for the Ozarks NCORP, Springfield
Mercy Hospital Springfield, Springfield
CoxHealth South Hospital, Springfield
University of Oklahoma Health Sciences Center, Oklahoma City
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa
Parkland Memorial Hospital, Dallas
Zale Lipshy University Hospital, Dallas
Clements University Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Scott and White Memorial Hospital, Temple
University Medical Center Brackenridge, Austin
University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora
Saint Alphonsus Cancer Care Center-Boise, Boise
Southwest Gynecologic Oncology Associates Inc, Albuquerque
University of New Mexico Cancer Center, Albuquerque
Women's Cancer Center of Nevada, Las Vegas
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Pacific Gynecology Specialists, Seattle
Fred Hutchinson Cancer Research Center, Seattle
Seattle Cancer Care Alliance, Seattle
Group Health Cooperative-Seattle, Seattle
Northwest Hospital, Seattle
University of Washington Medical Center, Seattle
Providence Regional Cancer Partnership, Everett
PeaceHealth Medical Group PC, Bellingham
Skagit Valley Hospital Regional Cancer Care Center, Mount Vernon
Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton
Harrison Medical Center, Bremerton
Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo
Olympic Medical Cancer Care Center, Sequim
MultiCare Tacoma General Hospital, Tacoma
Saint Joseph Medical Center, Tacoma
Wenatchee Valley Hospital and Clinics, Wenatchee
Cancer Care Northwest - Spokane South, Spokane
Rockwood Cancer Treatment Center-DHEC-Downtown, Spokane
Providence Saint Mary Regional Cancer Center, Walla Walla
Smilow Cancer Hospital Care Center at Saint Francis, Hartford
The Hospital of Central Connecticut, New Britain
Saint Joseph Mercy Hospital, Ann Arbor
Cooper Hospital University Medical Center, Camden
Women and Infants Hospital, Providence
Swedish Medical Center-First Hill, Seattle
Collaborators (1)
NRG Oncology
OTHER
National Cancer Institute (NCI)
NIH